HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiobiological effects of multiple vs. single low-dose pre-irradiation on the HT29 cell line.

AbstractAIM OF THE STUDY:
Aim of the study was to compare radiobiological effects of multiple vs. single low-dose pre-irradiation on the HT29 cell line. This regime is designed to be as similar as possible to fractionated tumour radiotherapy treatment, and to provide data on radiobiological effects on human tumour cells.
MATERIAL AND METHODS:
The cell line used in the study was HT29 (human colorectal adenocarcinoma, American Type Culture Collection HTB-38™). Also, for comparison, the MRC5 cell line (human foetal lung fibroblasts, American Type Culture Collection CCL 171) was used. Four-day treatment in a 4 × 2 Gy regime was performed. Cell viability was evaluated by tetrazolium colorimetric MTT assay.
RESULTS:
Multiple low-dose pre-irradiation induced a stronger radioadaptive response compared to single low-dose application in the HT29 cell line. Multiple pre-irradiation with 0.03 Gy and 0.05 Gy caused radioadaptive effects, while in both single and multiple low-dose pre-irradiation regimes 0.07 Gy led to radiosensitivity. Radiobiological effects induced in the HT29 cell line by low-dose pre-irradiation were evidently weak during the treatment time, because a single low-dose applied only on the first day gave no radioadaptive effects. In the MRC5 cell line different effects were registered, since radioadaptive response has not been observed after multiple or single pre-irradiation.
CONCLUSIONS:
The obtained data are interesting, especially for the possible application of low-dose pre-irradiation in radiotherapy.
AuthorsIgor Djan, Slavica Solajic, Mihajla Djan, Natasa Vucinic, Dunja Popovic, Miroslav Ilic, Silvija Lučić, Gordana Bogdanovic
JournalContemporary oncology (Poznan, Poland) (Contemp Oncol (Pozn)) Vol. 18 Issue 4 Pg. 230-3 ( 2014) ISSN: 1428-2526 [Print] Poland
PMID25258579 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: